David Arnold

Partner

London
Willkie Farr & Gallagher (UK) LLP
Citypoint, 1 Ropemaker Street
London EC2Y 9AW
T +44 20 3580 4720
F +44 20 3580 4800
darnoldwillkie.com

David Arnold is a partner in the Corporate & Financial Services Department and the Private Equity Practice Group. His practice is focused on representing financial investors and corporate clients across Europe and the US on mergers and acquisitions, divestments, restructurings, capital raisings and general corporate law matters.

David was previously recognised in Legal 500.

David Arnold is a partner in the Corporate & Financial Services Department and the Private Equity Practice Group. His practice is focused on representing financial investors and corporate clients across Europe and the US on mergers and acquisitions, divestments, restructurings, capital raisings and general corporate law matters.

David was previously recognised in Legal 500.

Selected Significant Matters

David has advised on the following significant matters*:

  • Levine Leichtman Capital Partners in its acquisition of SiPM, in partnership with management and its founding partners
  • CapVest Partners LLP and its portfolio company Valeo Foods in its acquisition of Campbell’s European Chips Business
  • CapVest Partners and its portfolio company Karro Food Group in the acquisition of Young’s Seafood
  • CapVest Partners and Valeo Food Group on Valeo’s acquisition of the Tangerine Confectionery Group from Blackstone
  • Law Business Research, a portfolio company of Levine Leichtman Capital Partners, on its acquisition of Globe Business Media Group
  • New Mountain Capital on its sale of talent acquisition and management company Alexander Mann Solutions to OMERS Private Equity for £820 million
  • EMR Capital in relation to its consortium arrangements with PT Adaro Energy Tbk and the consortium’s acquisition of Rio Tinto’s 80% interest in the Kestrel coking coal mine for total cash consideration of $2.25 billion
  • Actera Group and Esas Holdings on the sale of shipping operator U.N. Ro-Ro to DFDS for approximately €950 million ($1.17 billion)
  • Marguerite Adviser S.A. on the sale by The Marguerite Fund of a portfolio of five European infrastructure assets to Pantheon
  • Cartesian Group LLC in its investment in Flybondi, Argentina’s first ultra-low cost airline
  • CapVest Partners on its acquisition of Karro Food Group, a leading UK-based pork processing firm, from Endless LLP
  • Solera Holdings Inc. on its acquisition of Autodata, a leading UK provider of digital technical solutions to the automotive industry
  • Modine Manufacturing Company, a diversified global leader in thermal management technology and solutions, in a definitive agreement to acquire Luvata Heat Transfer Solutions for a total consideration of approximately $422 million, to be financed through a combination of cash, debt, and $25 million of Modine common stock
  • Maxis Communications Berhad in a transaction with Reliance Communications (RCOM) to combine RCOM’s Indian wireless business with Aircel Limited, a subsidiary of Maxis. The transaction is the largest ever consolidation in the Indian telecommunications sector and one of the largest merger of equals in India
  • Levine Leichtman Capital Partners on its acquisition of GL Education
  • Actera Group and others on their sale of Mars Entertainment Group to an investment group led by CJ CGV at an enterprise value of approximately $800 million
  • I Squared Capital on its acquisition of Viridian
  • Montagu Private Equity on its sale of CliniSys to Roper Technologies
  • S C Johnson & Son Inc. on its acquisition of DEB Group
  • Goldentree Asset Management LP and the other shareholders of the Peermont Group, in the agreement with Sun International to sell Peermont to Sun International for approximately $775 million
  • Searchlight Capital Partners on its acquisition of Ocean Outdoor
  • Solera Inc. on its acquisition of CAP Automotive
  • CDW Corporation on its acquisition of Kelway Limited
  • Summit Partners on its acquisition of Independent Vetcare Holdings
  • GTCR in its acquisition of Callcredit Information Group Limited
  • Bain Capital and Altor on their agreement to acquire EWOS (a world leading fish feed business) from Cermaq ASA at a value of NOK 6.5 billion (approximately €830 million).
  • ABRY Partners on its acquisition of Basefarm AS
  • ABRY Partners on its investment in Claranet
  • Cinven and Goldman Sachs Capital Partners on their €1.8 billion sale of Ahlsell to CVC Capital Partners
  • Apax Partners on its $830 million buyout of leading IT security company Sophos plc
  • Cinven Limited on its acquisition of Coor Service Management Group for €536 million
  • Apax Partners and the founder shareholder on the disposal of Healthcare at Home Limited to Hutton Collins
  • Blackstone Group International on the acquisition by the Merlin Group of the Tussauds Group for more than £1 billion
  • Lloyds, BoS, HSBC and Nomura as senior lenders on the £535 million acquisition by Charterhouse of Wood McKenzie
  • Abbey on its acquisition of Bradford & Bingley’s retail deposit business and branch network
  • Imperial Energy plc on the recommended cash offer for that company on ONGC for more than £1.4 billion
  • Titan Cement Group on its agreement to dispose of a minority stake in its Egyptian operations to the International Finance Corporation at an enterprise value of €650 million
  • Cognetas LLP on its disposal of the Aliplast Group, a European supplier of aluminum profile systems, to an MBO team-led consortium backed by Sagard and Ergon for €430 million
  • General Atlantic in connection with its investments in Torex Retail and Liberata
  • Apax Partners in connection with its £2.35 billion acquisition (as part of a consortium involving Netcare, London & Regional, and Brockton Capital) of General Healthcare Group
  • Jane Shepherdson and the management team of Whistles on the acquisition of that company
  • Biofusion Plc on its 10 year IP commercialisation agreement with the University of Sheffield and its associated initial public offering on AIM in 2005, and its subsequent 10-year IP commercialisation agreement with the University of Cardiff and associated placing in 2006 and further equity raisings in 2008 and 2009
  • Neutec Pharma plc on the recommended cash offer for that company by Novartis for more than £300 million

*David advised on some of these matters prior to joining Willkie.

Prior Experience

Prior to joining Willkie in 2019, David was a partner at Kirkland & Ellis International LLP.

Publications / News / Events